OXCT2

Chr 1

3-oxoacid CoA-transferase 2

Also known as: FKSG25, SCOTT

The protein encoded by OXCT2 is a mitochondrial enzyme that catalyzes the transfer of CoA from succinate to acetoacetate, serving as a key enzyme in ketone body catabolism. Mutations cause autosomal recessive intellectual disability with seizures and hypotonia, typically presenting in infancy or early childhood. This gene is extremely intolerant to loss-of-function variants (pLI near 0), suggesting that biallelic mutations are required for disease manifestation.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.96
Clinical SummaryOXCT2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
8 unique Pathogenic / Likely Pathogenic· 76 VUS of 89 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.96LOEUF
pLI 0.000
Z-score -1.56
OE 1.80 (0.941.96)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.64Z-score
OE missense 0.89 (0.800.99)
233 obs / 262.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE1.80 (0.941.96)
00.351.4
Missense OE0.89 (0.800.99)
00.61.4
Synonymous OE0.79
01.21.6
LoF obs/exp: 8 / 4.4Missense obs/exp: 233 / 262.1Syn Z: 1.86
DN
0.6452th %ile
GOF
0.6442th %ile
LOF
0.3940th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

89 submitted variants in ClinVar

Classification Summary

Pathogenic6
Likely Pathogenic2
VUS76
Likely Benign3
Conflicting1
6
Pathogenic
2
Likely Pathogenic
76
VUS
3
Likely Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
6
0
6
Likely Pathogenic
0
0
2
0
2
VUS
0
72
4
0
76
Likely Benign
0
3
0
0
3
Benign
0
0
0
0
0
Conflicting
1
Total07512088

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

OXCT2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found